Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Andrew Meds

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Andrew Meds head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 88 · Grade C

Andrew Meds

Visit Andrew Meds Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 75 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Andrew Meds a bad call — it's best for cash-pay patients comparing a monthly prescription with the full cost of a longer prepaid plan. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
77
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
81
Track Record
88
74
CoreAge RxBrief Score 94 · 75Andrew Meds

Price, coverage & the tracker

CoreAge RxAndrew Meds
Brief Score94/100 (A)75/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$199/mo paid monthly

Prepaid options: $549/3 months, $999/6 months or $1,788/12 months.

Full price details

$199/month month to month; compounded injection; prepaid options $549/3 months, $999/6 months or $1,788/12 months

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$299/mo paid monthly

Prepaid options: $797/3 months, $1,494/6 months or $2,748/12 months.

Full price details

$299/month month to month; compounded injection; prepaid options $797/3 months, $1,494/6 months or $2,748/12 months

CoverageUS only; restrictions by state, confirmed at intakeAdvertises all 50 states and DC; visit format and prescription availability vary
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Andrew Meds: Monthly injections are $199 semaglutide and $299 tirzepatide. Lower equivalents require prepaid terms. Cancel at least two days before renewal processing; the first renewal can process early.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.